Another area of concern to the industry was discussed at the 2015 ABPI Conference:The closing session of the 2015 ABPI Conference was focused on the reputation of the pharmaceutical industry: A panel discussion was part of this: I wonder if the panel considered this:Andrew McConaghie of PharmaPhorum recorded this passage:My view is that if the Pharmaceutical industry are concerned about their reputation then they should avoid such obvious scapegoating. Dr Goldacre has been and continues to be a world pioneer for scientific objectivity and it does…